235 related articles for article (PubMed ID: 35120771)
1. COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: A clarion call for maintaining mitigation and ramping-up research.
Wang L; Kaelber DC; Xu R; Berger NA
Blood Rev; 2022 Jul; 54():100931. PubMed ID: 35120771
[TBL] [Abstract][Full Text] [Related]
2. Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Between December 2020 and November 2021.
Wang W; Kaelber DC; Xu R; Berger NA
JAMA Oncol; 2022 Jul; 8(7):1027-1034. PubMed ID: 35394485
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 primary and breakthrough infections in patients with cancer: Implications for patient care.
Wang L; Wang W; Xu R; Berger NA
Best Pract Res Clin Haematol; 2022 Sep; 35(3):101384. PubMed ID: 36494154
[TBL] [Abstract][Full Text] [Related]
4. Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative.
Song Q; Bates B; Shao YR; Hsu FC; Liu F; Madhira V; Mitra AK; Bergquist T; Kavuluru R; Li X; Sharafeldin N; Su J; Topaloglu U
J Clin Oncol; 2022 May; 40(13):1414-1427. PubMed ID: 35286152
[TBL] [Abstract][Full Text] [Related]
5. Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer.
Gong IY; Vijenthira A; Powis M; Calzavara A; Patrikar A; Sutradhar R; Hicks LK; Wilton D; Singh S; Krzyzanowska MK; Cheung MC
JAMA Oncol; 2023 Mar; 9(3):386-394. PubMed ID: 36580318
[TBL] [Abstract][Full Text] [Related]
6. Risk of SARS-CoV-2 Breakthrough Infection in Vaccinated Cancer Patients: A Retrospective Cohort Study.
Rooney A; Bivona C; Liu B; Streeter D; Gong H; Khan Q
J Hematol Oncol; 2022 May; 15(1):67. PubMed ID: 35597960
[TBL] [Abstract][Full Text] [Related]
7. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.
Pagano L; Salmanton-García J; Marchesi F; Blennow O; Gomes da Silva M; Glenthøj A; van Doesum J; Bilgin YM; López-García A; Itri F; Nunes Rodrigues R; Weinbergerová B; Farina F; Dragonetti G; Berg Venemyr C; van Praet J; Jaksic O; Valković T; Falces-Romero I; Martín-Pérez S; Jiménez M; Dávila-Valls J; Schönlein M; Ammatuna E; Meers S; Delia M; Stojanoski Z; Nordlander A; Lahmer T; Imre Pinczés L; Buquicchio C; Piukovics K; Ormazabal-Vélez I; Fracchiolla N; Samarkos M; Méndez GA; Hernández-Rivas JÁ; Espigado I; Cernan M; Petzer V; Lamure S; di Blasi R; Marques de Almedia J; Dargenio M; Biernat MM; Sciumè M; de Ramón C; de Jonge N; Batinić J; Aujayeb A; Marchetti M; Fouquet G; Fernández N; Zambrotta G; Sacchi MV; Guidetti A; Demirkan F; Prezioso L; Ráčil Z; Nucci M; Mladenović M; Liévin R; Hanáková M; Gräfe S; Sili U; Machado M; Cattaneo C; Adžić-Vukičević T; Verga L; Labrador J; Rahimli L; Bonanni M; Passamonti F; Pagliuca A; Corradini P; Hoenigl M; Koehler P; Busca A; Cornely OA
Blood; 2022 Dec; 140(26):2773-2787. PubMed ID: 36126318
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
Pagano L; Salmanton-García J; Marchesi F; Busca A; Corradini P; Hoenigl M; Klimko N; Koehler P; Pagliuca A; Passamonti F; Verga L; Víšek B; Ilhan O; Nadali G; Weinbergerová B; Córdoba-Mascuñano R; Marchetti M; Collins GP; Farina F; Cattaneo C; Cabirta A; Gomes-Silva M; Itri F; van Doesum J; Ledoux MP; Čerňan M; Jakšić O; Duarte RF; Magliano G; Omrani AS; Fracchiolla NS; Kulasekararaj A; Valković T; Poulsen CB; Machado M; Glenthøj A; Stoma I; Ráčil Z; Piukovics K; Navrátil M; Emarah Z; Sili U; Maertens J; Blennow O; Bergantim R; García-Vidal C; Prezioso L; Guidetti A; Del Principe MI; Popova M; de Jonge N; Ormazabal-Vélez I; Fernández N; Falces-Romero I; Cuccaro A; Meers S; Buquicchio C; Antić D; Al-Khabori M; García-Sanz R; Biernat MM; Tisi MC; Sal E; Rahimli L; Čolović N; Schönlein M; Calbacho M; Tascini C; Miranda-Castillo C; Khanna N; Méndez GA; Petzer V; Novák J; Besson C; Duléry R; Lamure S; Nucci M; Zambrotta G; Žák P; Seval GC; Bonuomo V; Mayer J; López-García A; Sacchi MV; Booth S; Ciceri F; Oberti M; Salvini M; Izuzquiza M; Nunes-Rodrigues R; Ammatuna E; Obr A; Herbrecht R; Núñez-Martín-Buitrago L; Mancini V; Shwaylia H; Sciumè M; Essame J; Nygaard M; Batinić J; Gonzaga Y; Regalado-Artamendi I; Karlsson LK; Shapetska M; Hanakova M; El-Ashwah S; Borbényi Z; Çolak GM; Nordlander A; Dragonetti G; Maraglino AME; Rinaldi A; De Ramón-Sánchez C; Cornely OA;
J Hematol Oncol; 2021 Oct; 14(1):168. PubMed ID: 34649563
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2.
Di Fusco M; Moran MM; Cane A; Curcio D; Khan F; Malhotra D; Surinach A; Miles A; Swerdlow D; McLaughlin JM; Nguyen JL
J Med Econ; 2021; 24(1):1248-1260. PubMed ID: 34844493
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies.
Chien KS; Peterson CB; Young E; Chihara D; Manasanch EE; Ramdial JL; Thompson PA
Blood Adv; 2023 Oct; 7(19):5691-5697. PubMed ID: 36696472
[TBL] [Abstract][Full Text] [Related]
12. Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population.
Butt AA; Yan P; Shaikh OS; Mayr FB; Omer SB
Clin Infect Dis; 2022 Aug; 75(1):e849-e856. PubMed ID: 34893812
[TBL] [Abstract][Full Text] [Related]
13. When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities.
Wang Q; Berger NA; Xu R
Blood Rev; 2021 May; 47():100775. PubMed ID: 33187811
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 breakthrough infections and hospitalizations among vaccinated patients with dementia in the United States between December 2020 and August 2021.
Wang L; Davis PB; Kaelber DC; Xu R
Alzheimers Dement; 2023 Feb; 19(2):421-432. PubMed ID: 35417628
[TBL] [Abstract][Full Text] [Related]
15. The Risk of Hospitalization and Mortality After Breakthrough SARS-CoV-2 Infection by Vaccine Type: Observational Study of Medical Claims Data.
Kshirsagar M; Nasir M; Mukherjee S; Becker N; Dodhia R; Weeks WB; Ferres JL; Richardson B
JMIR Public Health Surveill; 2022 Nov; 8(11):e38898. PubMed ID: 36265135
[TBL] [Abstract][Full Text] [Related]
16. Timing of last COVID-19 vaccine dose and SARS-CoV-2 breakthrough infections in fully (boosted) vaccinated healthcare personnel.
Maltezou HC; Gamaletsou MN; Giannouchos TV; Koukou DM; Karapanou A; Sourri F; Syrimi N; Lemonakis N; Peskelidou E; Papanastasiou K; Souliotis K; Lourida A; Panagopoulos P; Hatzigeorgiou D; Sipsas NV
J Hosp Infect; 2023 Feb; 132():46-51. PubMed ID: 36473554
[TBL] [Abstract][Full Text] [Related]
17. Association of Psychiatric Disorders With Incidence of SARS-CoV-2 Breakthrough Infection Among Vaccinated Adults.
Nishimi K; Neylan TC; Bertenthal D; Seal KH; O'Donovan A
JAMA Netw Open; 2022 Apr; 5(4):e227287. PubMed ID: 35420660
[TBL] [Abstract][Full Text] [Related]
18. Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021.
Steele MK; Couture A; Reed C; Iuliano D; Whitaker M; Fast H; Hall AJ; MacNeil A; Cadwell B; Marks KJ; Silk BJ
JAMA Netw Open; 2022 Jul; 5(7):e2220385. PubMed ID: 35793085
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US.
Lang R; Humes E; Coburn SB; Horberg MA; Fathi LF; Watson E; Jefferson CR; Park LS; Gordon KS; Akgün KM; Justice AC; Napravnik S; Edwards JK; Browne LE; Agil DM; Silverberg MJ; Skarbinski J; Leyden WA; Stewart C; Hogan BC; Gebo KA; Marconi VC; Williams CF; Althoff KN;
JAMA Netw Open; 2022 Oct; 5(10):e2236397. PubMed ID: 36227594
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 infection in patients with haematological malignancies: A single-centre survey in the latest Omicron wave in China.
Zhu X; Jiang Q; Lu J; Sun Y; Zhao X; Yang S; Tang F; Yu W; Zhao T; Liu X; Jia J; Duan W; Hu L; Wang J; Liu Y; Peng N; Dou X; Ma R; Fu Q; Wang H; Liu K; Huang X; Jiang H
Br J Haematol; 2023 Jul; 202(1):31-39. PubMed ID: 37092433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
